165 related articles for article (PubMed ID: 16527392)
1. Quantitative cytology on bladder wash versus voided urine: a comparison of results.
Moonen PM; Peelen P; Kiemeney LA; Boon ME; Schalken JA; Witjes JA
Eur Urol; 2006 Jun; 49(6):1044-9; discussion 1049-50. PubMed ID: 16527392
[TBL] [Abstract][Full Text] [Related]
2. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
Kumar A; Kumar R; Gupta NP
Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
[TBL] [Abstract][Full Text] [Related]
3. UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer.
Moonen PM; Merkx GF; Peelen P; Karthaus HF; Smeets DF; Witjes JA
Eur Urol; 2007 May; 51(5):1275-80; discussion 1280. PubMed ID: 17084511
[TBL] [Abstract][Full Text] [Related]
4. Quick-staining urinary cytology and bladder wash image analysis with an integrated risk classification: a worthwhile improvement in the follow-up of bladder cancer?
Wiener HG; Remkes GW; Schatzl G; Susani M; Breitenecker G
Cancer; 1999 Oct; 87(5):263-9. PubMed ID: 10536351
[TBL] [Abstract][Full Text] [Related]
5. Quanticyt: karyometric analysis of bladder washing for patients with superficial bladder cancer.
van der Poel HG; Witjes JA; van Stratum P; Boon ME; Debruyne FM; Schalken JA
Urology; 1996 Sep; 48(3):357-64. PubMed ID: 8804485
[TBL] [Abstract][Full Text] [Related]
6. Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer?
Bollmann M; Heller H; Bánkfalvi A; Griefingholt H; Bollmann R
BJU Int; 2005 Jun; 95(9):1219-25. PubMed ID: 15892805
[TBL] [Abstract][Full Text] [Related]
7. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
[TBL] [Abstract][Full Text] [Related]
8. Voided urinary cytology in bladder cancer: is it time to review the indications?
Talwar R; Sinha T; Karan SC; Doddamani D; Sandhu A; Sethi GS; Srivastava A; Narang V; Agarwal A; Adhlakha N
Urology; 2007 Aug; 70(2):267-71. PubMed ID: 17826487
[TBL] [Abstract][Full Text] [Related]
9. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.
Daniely M; Rona R; Kaplan T; Olsfanger S; Elboim L; Freiberger A; Lew S; Leibovitch I
Cancer; 2007 Dec; 111(6):517-24. PubMed ID: 17963263
[TBL] [Abstract][Full Text] [Related]
10. Conventional bladder wash cytology performed by four experts versus quantitative image analysis.
van der Poel HG; Boon ME; van Stratum P; Ooms EC; Wiener H; Debruyne FM; Witjes JA; Schalken JA; Murphy WM
Mod Pathol; 1997 Oct; 10(10):976-82. PubMed ID: 9346176
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of urinary bladder cancer antigen and urine cytology in the diagnosis of bladder cancer.
Shoshtari MA; Soleimani M; Moslemi M
Urol J; 2005; 2(3):137-40. PubMed ID: 17602416
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of urinary NMP22 (nuclear matrix protein 22) bladder chek in the detection of patients with bladder cancer].
Kitsukawa S; Yamamoto Y; Hosoda S; Otsuru N; Matsumoto T; Matsumoto T; Aizawa T; Noda K; Ito T
Hinyokika Kiyo; 2006 Mar; 52(3):167-72. PubMed ID: 16617867
[TBL] [Abstract][Full Text] [Related]
13. DNA breaks as measured by the alkaline comet assay in exfoliated cells as compared to voided urine cytology in the diagnosis of bladder cancer: a study of 105 subjects.
Fracasso ME; Franceschetti P; Doria D; Talamini G; Bonetti F
Mutat Res; 2004 Nov; 564(1):57-64. PubMed ID: 15474411
[TBL] [Abstract][Full Text] [Related]
14. Analysis of atypical urine cytology in a tertiary care center.
Deshpande V; McKee GT
Cancer; 2005 Dec; 105(6):468-75. PubMed ID: 16080177
[TBL] [Abstract][Full Text] [Related]
15. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
Bergman J; Reznichek RC; Rajfer J
BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
[TBL] [Abstract][Full Text] [Related]
16. Urine cytology after flexible cystoscopy.
Herr HW; Regan M
BJU Int; 2005 Oct; 96(6):796-7. PubMed ID: 16153203
[TBL] [Abstract][Full Text] [Related]
17. Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer.
Svatek RS; Herman MP; Lotan Y; Casella R; Hsieh JT; Sagalowsky AI; Shariat SF
Cancer; 2006 Apr; 106(8):1701-7. PubMed ID: 16541433
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of voided urine cytology, nuclear matrix protein-22 and bladder tumor associated antigen tests for bladder cancer of geriatric male patients in Taiwan, China.
Tsui KH; Chen SM; Wang TM; Juang HH; Chen CL; Sun GH; Chang PL
Asian J Androl; 2007 Sep; 9(5):711-5. PubMed ID: 17712491
[TBL] [Abstract][Full Text] [Related]
19. Nuclear matrix protein 22 as adjunct to urine cytology and cystoscopy in follow-up of superficial TCC of urinary bladder.
Gupta NP; Sharma N; Kumar R
Urology; 2009 Mar; 73(3):592-6; discussion 596-7. PubMed ID: 19168205
[TBL] [Abstract][Full Text] [Related]
20. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
Asali MG; Kaneti J; Manor E
Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]